Evaluation of the anticonvulsant activity of 6-(4-chlorophenyoxy)-tetrazolo[5,1-a]phthalazine in various experimental seizure models in mice

Pharmacological Reports

Volumn 62, Issue 2, 2010, Pages 273-277

  Sun, Xian Yu ^b   Wei, Cheng Xi ^a   Deng, Xian Qing ^b   Sun, Zhi Gang ^a   Quan, Zhe Shan ^b  

^a INNER MONGOLIA UNIVERSITY FOR NATIONALITIES   (China)

^b YANBIAN UNIVERSITY   (China)

Author keywords

3 mercaptopropionic acid; Isoniazid; Maximal electroshock; Pentylenetetrazole; Tetrazolo 5,1 a phthalazine; Thiosemicarbazide

Indexed keywords

3 MERCAPTOPROPIONIC ACID; 6 (4 CHLOROPHENYOXY)TETRAZOLO[5,1 A]PHTHALAZINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ISONIAZID; PENTETRAZOLE; QUAN 0808; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG; 6-(4-CHLOROPHENOXY)TETRAZOLO(5,1-A)PHTHALAZINE; PHTHALAZINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; FEMALE; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; SEIZURE; TOXICITY TESTING; ANIMAL; DISEASE MODEL; SEIZURES;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; PHTHALAZINES; SEIZURES; TETRAZOLES;

EID: 77953309789     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70266-8     Document Type: Article

References (22)

1. Al-Soud YA, Al-Masoudi NA, Ferwanah Ael-R: Synthesis and properties of new substituted 1,2,4-triazoles: potential antitumor agents. Bioorg Med Chem, 2003, 8, 1701-1708.
2. Ambrogi V, Grandolini G, Perioli L, Giusti L, Lucacchini A, Martini C: Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VII. Synthesis and inhibition of benzodiazepine receptor binding of some 4,5- dihydro-tetrazolo[5,1-d]-1,5-benzothiazepines and 5-phenyl-s-triazolo[3,4-d]-1,5-benzothiazepines. Farmaco, 1993, 48, 665-676.
3. Bourgeois BF: New antiepileptic drugs. Arch Neurol, 1998, 55, 1181-1183.
4. Castel-Branco MM, Alves GL, Figueiredo IV, Falcao AC, Caramona MM: The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Methods Find Exp Clin Pharmacol, 2009, 31, 101-106.
5. Chen J, Sun XY, Chai KY, Lee JS, Song MS, Quan ZS: Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)- 3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3- a]quinolines. Bioorg Med Chem, 2007, 15, 6775-6781.
6. El-Gazzar AR, El-Enany MM, Mahmoud MN: Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones. Bioorg Med Chem, 2008 16, 3261-3273.
7. Gale K: GABA and epilepsy: basic concepts from preclinical research. Epilepsia, 1992, 33: S3-S 12.
8. Hamilton MA, Russo RC, Thurston RC: Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays. Env Sci Technol, 1977, 7, 714-719.
9. Israili ZH: Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. J Hum Hypertens, 2000, 14, Suppl 1, S73-86.
10. Karnik AV, Malviya NJ, Kulkarni AM, Jadhav BL: Synthesis and in vitro antibacterial activity of novel heterocyclic derivatives of 18-nor-equilenin. Eur J Med Chem, 2006, 41, 891-895.
11. Kupferberg HJ: Strategies for identifying and developing new anticonvulsant drugs. PharmWeekbl Sci, 1992, 14, 132-138.
12. Leppik IE: Antiepileptic drugs in development: prospects for the near future. Epilepsia, 1994, 35, 29-40.
13. Lin Z, Kadaba PK: Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents. Med Res Rev, 1997, 17, 537-572.
14. Löscher W: 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, amino-oxyacetic acid and gabaculine. Biochem Pharmacol, 1979, 28, 1397-1407.
15. Löscher W: New visions in the pharmacology of anticonvulsion. Eur J Pharmacol, 1998, 342, 1-13.
16. Okada R, Negishi N, Nagaya H: The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazolinduced seizures. Brain Res, 1989, 480, 383-387.
17. Olsen RW: GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem, 1981, 37, 1-13.
18. Perucca E: The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol, 1996, 42, 531-543.
19. Sun XY, Zhang L, Wei CX, Piao HR, Quan ZS: Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice. Pharmacol Rep, 2009, 61, 245-251.
20. Talarek S, Listos J, Fidecka S: Role of nitric oxide in the development of tolerance to diazepam-induced motor impairment in mice. Pharmacol Rep, 2008, 60, 475-482.
21. Wieland S, Belluzzi J, Hawkinson JE, Hogenkamp D, Upasani R, Stein L, Wood PL et al.: Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593. Psychopharmacology, 1997, 134, 46-54.
22. Zhang L, Guan LP, Sun XY, Wei CX, Chai KY, Quan ZS: Synthesis and anticonvulsant activity of 6-alkoxy- [1,2,4]triazolo[3,4-a]phthalazines. Chem Biol Drug Des, 2009, 73, 313-319.